Molecular Docking, Pre-ADME, And Pre-Tox Analysis Of Swainsonine And Castanospermine As Potential Glucokinase Activators

Abstract

In this research, we investigated the efficacy of Swainsonine and Castanospermine as GK activators in the treatment of type 2 diabetes. It was determined to perform a comprehensive investigation on the absorption, distribution, metabolism, excretion, and toxicity (ADMET) characteristics of the substances. After that, molecular docking experiments were carried out in order to explore the possible binding affinity of these compounds with the GK enzyme. Based on this discovery, it can be deduced that both chemicals possess the capability to create conventional hydrogen bonds with the GK enzyme, which indicates that they have the potential to operate as activators of the enzyme. It is possible to improve the efficiency of GK activation by using the tactic of synthesising a variety of semisynthetic derivatives as part of the overall plan. It is acceptable to contemplate the possibility of either of these compounds being developed further into a GK activator given that both of them demonstrate a variety of drug-like features.